Video: Uncovering Kimia Farma's Financial Problems Due to Excessive Investment
Jakarta, CNBC Indonesia - Chief Operating Officer of BPI Danantara and Head of the State-Owned Enterprise Regulatory Body, Dony Oskaria, stated that BPI Danantara is ensuring the streamlining process of state-owned enterprises is aimed at improving their performance, so this process will not impact employees, including no layoffs.
Dony Oskaria said efforts to address the problems of state-owned enterprises will reduce losses and save up to Rp 60 trillion, so that improvement efforts at Telkomsel and PT Pos will not involve employee layoffs.
On the pharmaceutical state-owned enterprise side, Danantara is carrying out transformation through a holding company under Bio Farma. One of the improvements is being made at Kimia Farma, which is facing quite deep financial problems caused by unmeasured investment through the construction of large factories with low utilisation, as well as Kimia Farma pharmacies which have 1,000 outlets with investment problems.
Danantara is carrying out a fundamental transformation of Kimia Farma through management and business restructuring so that it can be saved and has already recorded a profit. However, Indofarma is experiencing serious problems with its subsidiary, PT Indofarma Global Medika (IGM), which is undergoing bankruptcy proceedings.
Source: jawawa.id (https://jawawa.id/newsitem/video-uncovering-kimia-farmas-financial-problems-due-to-excessive-investment-1787813475)
Originally published by CNBC Indonesia (https://www.cnbcindonesia.com/news/20260827090724-8-762608/video-bongkar-masalah-keuangan-kimia-farma-akibat-investasi-berlebih), translated from Indonesian